||EPS - Basic
||Market Cap (m)
Angle Share Discussion Threads
Showing 44326 to 44349 of 44350 messages
|miavoce, I like the fact that ii's are here, however is that a guarantee of success? It's definitely not, as they dont get it right all the time, however lets hope theyhave on this occasion. share price is pretty stable anyway.|
|I do hope that, on Thursday, we find out who the big partner is.|
|I think it's nice to see the two filtered boys having a little chat to each other over the weekend. Keeps them out of trouble elsewhere. ;-)|
|Fray is a complete muppet, being hanging around AGL for years. Just a bit sad really, but will be gone for good soon enough. Once those Ovarian results are out and the share price is heading north he will have nowhere to hide.|
|Fraybentos- what is your beef? If you dislike AGL so much, why post?? Why not just move on - unless you get off by attempting to irritate other holders. For sure your posts do not inform...|
|This is the perfect place to discuss the pros and cons of AGL. However, why do the critics keep popping up only when the shares are falling? Why do they keep copy and pasting the same points, often in capitals for effect?
Personally I have no problem with a critic posting their thoughts about AGL but just because others don't see it your way, don't throw you toys out of the pram.|
|I guess you class ii's who invested at 64p as mug punters fray ?|
|what is fair value for agl
board of directors underperforming
ctcs will not in the long term be used for cancer detection
there is no proof of the value of ctcs for any other purpose
no fda approval this year
machine not fully automated
delays in trials starting
further dilution required absent deal
lack of market confidence
given revenues slow prospects and the above difficulties £10m perhaps
on a good day
so without a deal or pumped share price agl is worthless
dilution required will be too high to make investable
good news for mug punters the share price is higher than it should be
bad news for mug punters the share price is falling|
|I rate ANGLE a BUY at this level.
Im hoping for good news and theres a chance the share price will go up.
My only mistake was to buy too many shares in angle.
Ive reduced by over half, now hold 18,000 or so, still far far too many.|
|That is your opinion. What you term speculation i term critical thinking.
WHAT IF COMPETITORS ARE CATCHING UP?
WHAT IF SPECIFICITY IS NOT QUITE WHAT ITS CLAIMED?
WHAT IF WE ARE LOSING OUR ADVANTAGE?
DO WE NEED A STRONG PARTNER?
WHAT MAKES FOR A STRONG SHARE PRICE!
These are not speculations these are debating points, this is learning not everything is rose tinted.
It is not this rubbish at all as is your claim. I have found the debate around these points interesting.
I wholeheartedly reject your claim.|
|but it's is all rubbish and not useful for anybody!|
|Im afraid angle is a very speculative share. It is not a gsk or a lloy.
Therefore : people speculate!|
|thank you miacoce and trotter for injecting some sense of realism and sobriety on this board- as always so many people here are speculating d wish they stop|
Epic are interesting, not least because they have some of the kind of pharma tie ups we might hope to see from AGL in the future. Very high quality BOD as well. Like a lot of US CTC co's they seem to be CLIA oriented.
"No Cell Left Behind", sounds kind of caring.:)|
the way a company finances its growth ( dilution of shares)
are the 4 main things which influence a share price despite what magic product it may have.|
|I doubt we will get any news about partner tie up in the interims Escape - this would be big news and would be announced as soon as it happens - the chances of it happening on the exact day of the interims would be very slim.
I hope to see good sales growth and good progress on Ovarian and MBC trials.
Hi Bookbroker, other than the share price performance, in what way has the progress over the last 12 been a monstrous disappointment ? Angle appear to be progressing to plan and we are seemingly on track to have the first FDA approved CTC capture and harvesting tool. Given the potential market size and the fact that we are ahead of the field it seems a bit nonsensical to pronounce the co dead in the water.|
|It cant be long now, 6 days maximum to wait for what i hope will be full update , giving more information about sales, prospects, the partner tie up.
Hopefully it will enable investors to clearly see the way forward for angle and to know the future is sound and funding is in place from a large company partner with muscle and clout and influence where angle needs to drive forward.|
|I think this co. Is dead in the water, Newland has been talking it up suggesting big news is on the way, but frankly this has been a monstrous disappointment, I think that Parsotix has a very limited role as a research tool and that's about it! So much hope coupled with tangible limitations!|
|If Parsortix is used as a screening test in "healthy" subjects I would hope the Parsortix would pick up prostate cancer early, before there is a tumour of a sufficient size to show on MRI.|
|If liquid biopsy using Parsortix proves to be as effective as MRI scan in detecting prostate cancer, then there is every chance that the NHS will be trail blazers using this product, because it will be cheaper and more accessible than an MRI scanner.|
|Why don't you just ask Andrew these questions? Why bother arguing back and forth without all the facts? It's just confuses readers and creates uncertainty on the BBWe have the benefit of the most responsive CEO on the AIM, use him.|
|Semoper all the other labs I have looked at that offer CTC testing have this 96 hour restriction for what is already an FDA Approved test, so obviously the FDA don't have a problem with it.
handling CTC samples is well established procedure and has been going on for over a decade, the need to treat CTC samples rapidly is well documented elsewhere. It's not an insurmounable issue re leasing extra machines, it just pushes the cost up/hassle factor somewhat, if you are a hospital administrator. There is little chance imo that the NHS will be significant trailblazers with this product anyway.|
|That is what a blood test for ctc's would allow,BUT you have to change the dinosaur's within the medical profession ways of doing things !
In the current world the money saving aspect is greater than ever and that is what will make it win in the end. It still takes sometime to culture the solid biopsy by the way!
How well Angle has done in the past few years time will tell,BUT any competitor will probably find it harder without the first mover advantage that parsortix has or had.
Because they will need something significantly more effective to yet again change those dinosaurs minds !
That is the play and time will tell.....|
|Banshee I think that AGL have had to show to the FDA that blood samples can hang around for a reasonable time at different temperatures.
If the demand is high for the test, extra machines will have to be bought/leased.
If it were me, I would be prepared to pay for my test and not rely on the machinations of the NHS.|